• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[新型冠状病毒肺炎及新发传染病的免疫学研究]

[Immunological research of COVID-19 and emerging infectious diseases].

作者信息

Cao X T

机构信息

College of Life Sciences, Nankai University, Tianjin 300071, China Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing 100005, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2021 Jan 5;101(1):1-6. doi: 10.3760/cma.j.cn112137-20201211-03336.

DOI:10.3760/cma.j.cn112137-20201211-03336
PMID:33423443
Abstract

Immune function plays a crucial role for the body to resist virus infection. This paper summarizes the research progress of humoral and cellular immune responses and immunopathology induced by COVID-19 patients and related virus infection, and analyzes the research and development status of COVID-19 vaccine and antibody drugs.

摘要

免疫功能对机体抵抗病毒感染起着至关重要的作用。本文综述了新型冠状病毒肺炎（COVID-19）患者及相关病毒感染所诱导的体液免疫和细胞免疫反应以及免疫病理学的研究进展，并分析了COVID-19疫苗和抗体药物的研发现状。

相似文献

1
[Immunological research of COVID-19 and emerging infectious diseases].[新型冠状病毒肺炎及新发传染病的免疫学研究]
Zhonghua Yi Xue Za Zhi. 2021 Jan 5;101(1):1-6. doi: 10.3760/cma.j.cn112137-20201211-03336.
2
[Progress in research of specific antibody dynamic characteristics in patients with COVID-19].[新型冠状病毒肺炎患者特异性抗体动态特征的研究进展]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Jan 10;42(1):39-43. doi: 10.3760/cma.j.cn112338-20200809-01047.
3
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.新型冠状病毒感染恢复期个体中 SARS-CoV-2 特异性体液和细胞免疫的检测。
Immunity. 2020 Jun 16;52(6):971-977.e3. doi: 10.1016/j.immuni.2020.04.023. Epub 2020 May 3.
4
How easy will it really be to replicate the success of the covid-19 vaccine with neglected infectious diseases?要利用被忽视的传染病复制新冠疫苗的成功究竟会有多容易？
BMJ. 2021 Mar 10;372:n678. doi: 10.1136/bmj.n678.
5
[The Challenges of Vaccine Development Against Betacoronaviruses: Antibody Dependent Enhancement and Sendai Virus as a Possible Vaccine Vector].[针对β冠状病毒研发疫苗的挑战：抗体依赖性增强作用以及仙台病毒作为一种可能的疫苗载体]
Mol Biol (Mosk). 2020 Nov-Dec;54(6):922-938. doi: 10.31857/S0026898420060154.
6
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.SARS-CoV-2 感染免疫功能低下患者：体液免疫与细胞免疫。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000862.
7
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
8
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.无症状 COVID-19 患者的细胞介导和体液适应性免疫应答低于有症状 COVID-19 患者。
Eur J Immunol. 2020 Dec;50(12):2013-2024. doi: 10.1002/eji.202048915. Epub 2020 Nov 9.
9
Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.从内部寻找并消灭邪恶——将癌症免疫转化为对抗新冠病毒的力量。
Cancer Immunol Immunother. 2020 Jun;69(6):911-912. doi: 10.1007/s00262-020-02580-1.
10
The known unknowns of T cell immunity to COVID-19.新冠病毒 T 细胞免疫的已知未知数。
Sci Immunol. 2020 Nov 18;5(53). doi: 10.1126/sciimmunol.abe8063.